Connected Magazine
Shorla makes major push into the US
Cancer treatment Jylamvo is second that the Irish medical start-up has brought stateside in a year
Shorla Oncology, the Irish life sciences start-up, is gearing up for a greater push into the US market this year
At the end of December, the company announced the commercial launch of Jylamvo, an oral solution for treating acute lymphoblastic leukaemia, in the US.
According to the company, the FDA-approved oral solution is the first of its kind for adults in the US. The launch was run in partnership with Eversana, which specialises in commercialising ...
